Cargando…
Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes
Protein kinase C related kinase 1 (PRK1) is a component of Rho-GTPase, androgen receptor, histone demethylase and histone deacetylase signaling pathways implicated in prostate and ovarian cancer. Herein we describe the crystal structure of PRK1 in apo form, and also in complex with a panel of litera...
Autores principales: | Chamberlain, Philip, Delker, Silvia, Pagarigan, Barbra, Mahmoudi, Afshin, Jackson, Pilgrim, Abbasian, Mahan, Muir, Jeff, Raheja, Neil, Cathers, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128815/ https://www.ncbi.nlm.nih.gov/pubmed/25111382 http://dx.doi.org/10.1371/journal.pone.0103638 |
Ejemplares similares
-
Lestaurtinib induces DNA damage that is related to estrogen receptor activation
por: Ooka, Masato, et al.
Publicado: (2022) -
Novel roles of PRK1 and PRK2 in cilia and cancer biology
por: Patel, Hitesh, et al.
Publicado: (2020) -
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
por: Pinto, Nicole, et al.
Publicado: (2018) -
Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells
por: Köhler, Jens, et al.
Publicado: (2012) -
PRK Enhancement for Residual Refractive Error After Primary PRK: A Retrospective Study
por: Moshirfar, Majid, et al.
Publicado: (2021)